NT
Nula Therapeutics, Inc.
SEC filingBiotechnology · St. Petersburg, FL
Amount raised$7.4Msold at filing
Total offering$7.4M
Investors in the raise7count reported to the SEC
FiledMar 18, 2026first sale Feb 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jarod RutledgeDirector
Christopher ShepardExecutive Officer, Director
Nils ReggeDirector
Executive officers, directors and promoters as listed on the Form D.